Vasorelaxing effect of the Rho-kinase inhibitor, Y-27632, in isolated canine basilar arteries

Neurol Res. 2007 Jul;29(5):485-9. doi: 10.1179/016164107X164076.

Abstract

Objectives: Increased calcium sensitization mediated by Rho/Rho-kinase may be important in the pathogenesis of cerebral vasospasm. The effects of a highly selective Rho-kinase inhibitor, Y-27632, were investigated on spasmogen-induced contractions of canine basilar artery.

Methods: Typical spasmogenic substances present after subarachnoid hemorrhage (SAH), including prostaglandin F2a (PGF2a), 12-deoxyphorbol 13-isobutyrate (DPB), sphingosylpho-sphorylcholine (SPC) and high K+, were used in the study. Isometric tension was recorded in canine basilar artery rings in vitro. Intracellular calcium concentration ([Ca2+]i) and contraction force were measured simultaneously in fura-2-loaded canine basilar artery strips. The myosin light chain (MLC) phosphorylation levels were measured by glycerol gel electrophoresis followed by Western blotting.

Results: Isometric tension recording revealed that the Rho-kinase inhibitor, Y-27632, dose-dependently inhibited vasocontraction induced by PGF2a and SPC, but not that induced by DPB. Simultaneous recordings of [Ca2+]i and tension revealed that the vasorelaxing effect of Y-27632 was not associated with changes in [Ca2+]i, suggesting that Y-27632 may inhibit calcium sensitization. Vasocontraction induced by DPB was not inhibited by Y-27632, but was inhibited by staurosporine. Phosphorylation of MLC was increased by PGF2a and SPC, and significantly inhibited by Y-27632, whereas such phosphorylation was increased by DPB, but not significantly inhibited by Y-27632.

Discussion: Several spasmogenic mediators released after SAH may cause vasospasm through Rho-kinase-mediated increase in calcium sensitization. Rho-kinase inhibitors, including Y-27632, may be effective for the prevention of cerebral vasospasm after SAH.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amides / pharmacology*
  • Animals
  • Basilar Artery / drug effects*
  • Calcium / metabolism
  • Dinoprost / pharmacology
  • Dogs
  • Dose-Response Relationship, Drug
  • Enzyme Inhibitors / pharmacology*
  • In Vitro Techniques
  • Myosin Light Chains / metabolism
  • Phosphorylation / drug effects
  • Phosphorylcholine / analogs & derivatives
  • Phosphorylcholine / pharmacology
  • Pyridines / pharmacology*
  • Sphingosine / analogs & derivatives
  • Sphingosine / pharmacology
  • Vasodilation / drug effects*

Substances

  • Amides
  • Enzyme Inhibitors
  • Myosin Light Chains
  • Pyridines
  • sphingosine phosphorylcholine
  • Phosphorylcholine
  • Y 27632
  • Dinoprost
  • Sphingosine
  • Calcium